Detalhe da pesquisa
1.
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
Eur J Neurol
; 30(5): 1352-1363, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786305
2.
Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
Stroke
; 50(2): 498-500, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602354
3.
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS).
BMC Neurol
; 15: 110, 2015 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26162826
4.
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
Lancet Neurol
; 21(6): 511-519, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525250
5.
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design.
Eur Stroke J
; 4(2): 172-180, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31259265
6.
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Lancet Neurol
; 16(10): 781-788, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28780236